Loading clinical trials...
Loading clinical trials...
The investigators aim to study the predictive value of presepsin in ascites in newly admitted patients with chronic liver failure.
Presepsin is a plasmatic cleaved fragment of CD14. CD14 is a toll like receptor who has the role to identify certain lipopolysaccharides on the surface of bacteria (aerobes and anaerobes), thus promoting an inflammatory response. A study of 153 patients with liver cirrhosis published by a team of investigators from Iasi, Romania, has proven an useful role of plasma presepsin in early diagnosis of infections in patients in acute on chronic liver failure. In addition, plasma presepsin has been proposed as an independent predictor of mortality in patients with decompensated liver cirrhosis, without concomitant bacterial infections. Question to be answered by this study The investigators aim to evaluate the predictive role of ascites presepsin in patients with chronic liver failure. Hypothesis Presepsin levels in ascites may have a prognostic role in patients with ascites and chronic liver failure.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
"Agrippa Ionescu" Hospital
Bucharest, Romania
Start Date
August 1, 2024
Primary Completion Date
December 31, 2024
Completion Date
December 31, 2024
Last Updated
August 21, 2024
30
ESTIMATED participants
Determination of presepsin levels in ascites
DIAGNOSTIC_TEST
Lead Sponsor
Carol Davila University of Medicine and Pharmacy
NCT07343037
NCT07329036
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06831643